| Whiteoak Capital Pharma And Healthcare Fund Datagrid | ||||||
|---|---|---|---|---|---|---|
| Category | Pharma Fund | |||||
| BMSMONEY | Rank | N/A | ||||
| Rating | N/A | |||||
| Growth Option 12-12-2025 | ||||||
| NAV | ₹13.92(R) | +0.07% | ₹14.38(D) | +0.08% | ||
| Returns | 1Y | 3Y | 5Y | 7Y | 10Y | |
| Lumpsum | Regular | 4.24% | -% | -% | -% | -% |
| Direct | 6.06% | -% | -% | -% | -% | |
| Nifty Pharma TRI | 3.34% | 22.28% | 13.69% | 15.42% | 7.83% | |
| SIP (XIRR) | Regular | 9.4% | -% | -% | -% | -% |
| Direct | 11.31% | -% | -% | -% | -% | |
| Ratio | Sharpe Ratio | Sortino Ratio | Sterling Ratio | Jensen's Alpha | Treynor Ratio | |
| Risk | STD. Dev | VaR 1Y95% | Max DD | Beta | Semi Devi. | |
| Fund AUM | As on: 30/06/2025 | 326 Cr | ||||
| Top Pharma Fund | |||||
|---|---|---|---|---|---|
| Fund Name | Rank | Rating | |||
| Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | - | ||||
| Sbi Healthcare Opportunities Fund | - | ||||
NAV Date: 12-12-2025
| Scheme Name | NAV | Rupee Change | Percent Change |
|---|---|---|---|
| WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth | 13.92 |
0.0100
|
0.0700%
|
| WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth | 14.38 |
0.0100
|
0.0800%
|
Review Date: 12-12-2025
Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.
Data Source: www.amfiindia.com
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -1.63 | 0.95 |
-1.39
|
-2.37 | -0.47 | 10 | 13 | Average |
| 3M Return % | -1.21 | 2.12 |
-1.82
|
-3.32 | -0.88 | 4 | 13 | Very Good |
| 6M Return % | 4.08 | 4.02 |
1.17
|
-3.20 | 4.08 | 1 | 13 | Very Good |
| 1Y Return % | 4.24 | 3.34 |
-0.18
|
-4.93 | 5.22 | 3 | 13 | Very Good |
| 1Y SIP Return % | 9.40 |
4.77
|
1.55 | 9.51 | 2 | 13 | Very Good |
| KPIs* | Fund | Nifty Pharma TRI | Cat. Avg | Min | Max | Rank (In Cat.) | Performance |
|---|---|---|---|---|---|---|
| 1M Return % | -1.49 | 0.95 | -1.29 | -2.24 | -0.39 | 10 | 13 | Average |
| 3M Return % | -0.79 | 2.12 | -1.51 | -2.93 | -0.59 | 3 | 13 | Very Good |
| 6M Return % | 4.97 | 4.02 | 1.83 | -2.41 | 4.97 | 1 | 13 | Very Good |
| 1Y Return % | 6.06 | 3.34 | 1.11 | -3.51 | 6.46 | 2 | 13 | Very Good |
| 1Y SIP Return % | 11.31 | 6.14 | 2.67 | 11.31 | 1 | 13 | Very Good |
Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.
| Date | Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth | Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth |
|---|---|---|
| 12-12-2025 | 13.917 | 14.375 |
| 11-12-2025 | 13.907 | 14.363 |
| 10-12-2025 | 13.819 | 14.272 |
| 09-12-2025 | 13.853 | 14.306 |
| 08-12-2025 | 13.795 | 14.246 |
| 05-12-2025 | 14.019 | 14.476 |
| 04-12-2025 | 14.055 | 14.512 |
| 03-12-2025 | 13.998 | 14.453 |
| 02-12-2025 | 14.066 | 14.521 |
| 01-12-2025 | 14.111 | 14.567 |
| 28-11-2025 | 14.235 | 14.693 |
| 27-11-2025 | 14.103 | 14.557 |
| 26-11-2025 | 14.14 | 14.594 |
| 25-11-2025 | 14.031 | 14.481 |
| 24-11-2025 | 13.993 | 14.441 |
| 21-11-2025 | 14.008 | 14.455 |
| 20-11-2025 | 14.102 | 14.55 |
| 19-11-2025 | 14.093 | 14.54 |
| 18-11-2025 | 14.109 | 14.557 |
| 17-11-2025 | 14.219 | 14.669 |
| 14-11-2025 | 14.173 | 14.619 |
| 13-11-2025 | 14.161 | 14.607 |
| 12-11-2025 | 14.147 | 14.592 |
| Fund Launch Date: 06/Feb/2024 |
| Fund Category: Pharma Fund |
| Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved. |
| Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector |
| Fund Benchmark: BSE Healthcare Total Return Index |
Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.